Belviq or lorcaserin, is produced and distributed by Arena Pharmaceuticals. It was designed to aid weight loss by activating receptors that trigger the release of serotonin, a chemical in the brain that is responsible for letting your body know when it “feels full”. The new diet drug was initially tested and was denied approval by the United States Food and Drug Administration (FDA) in 2010 because of concerns that arose when lab rats which were given over 5 times the recommended dosage, developed heart valve disorders as well as increased tumors that were found in both the brain and breast. Over time these concerns were not found in human subjects and Belviq was FDA approved in May of 2012. Although the drug hasn’t increased the risk of cancer or heart valve issues, it does have several hazardous and potentially fatal side effects.

Some of the mild physical side effects that are experienced by patients taking Belviq include headache, drowsiness, back pain, nausea, dry mouth feeling tired, and constipation. Some of the more serious physical side effects can include stiff muscles, fever, rapid heart rate, loss of coordination, trouble breathing, swelling, low blood sugar and fainting. Along with the physical side effects that are associated with the diet drug, there are also several psychological effects that have surfaced among patients. Some of these effects include having unusual thoughts that result in extreme happiness or extreme bouts of sadness. Patients have also experienced having outer body occurrences where they have felt like they are standing beside themselves. Hallucinations, and suicidal thoughts and feelings have also been experienced from taking this drug. If you have taken this medication and have had any of these side effects it is highly recommended that you see medical attention.

The side effects that occur as a result of taking Belviq have increasingly been discovered over time and several have transpired from interacting with other medications. Some of the medications that interfere with Belviq include but are not limited to Dostinex, ADHD medications, insulin, blood pressure medications, narcotic pain relievers, MAO inhibitors, antidepressants, migraine medicines, cough and cold relievers, and erectile dysfunction medications. There may be several other medications that interfere with Belviq that may not have been discovered. If you are experiencing side effects as a result of taking Belviq with other drugs be sure to consult a physician to report these effects.

Buy Non Prescription Diet Pills Online

The Food and Drug Administration (FDA) has attempted with little success to rid the market of illegal and potentially harmful asian diet pills. These diet pills have led to the illness and death of thousands due to key ingredients like sibutramine and N-nitroso fenfluramine. These ingredients are appetite suppressants which are used to block the release of the neurotransmitters from leaving the brain making you feel full and as a result, eating less. In theory, these ingredients have proven effective for weight loss but come with deadly side effects, especially when manufactured and distributed in illegal doses up to three times the regulated daily amount. Asian diet pill manufacturers have been using a loophole to distribute diet pills that not only contain illegal amounts of listed key ingredients, but also by masking dangerous ingredients referring to them as “herbal ingredients,” or avoiding to identify them at all.

Chinese pill manufacturers have avoided safety tests used to identify health dangers by promoting diet pills and supplements as health foods and herbal remedies rather than pharmaceutical products. This allows manufacturers to skip regulatory procedures and put these products on the shelves without passing rigorous drug trials where potential dangers and side effects would have been recognized. The popularity of these diet pills has encouraged Chinese manufacturers to keep producing the drugs regardless of the rising public health risks that have been made apparent. Interestingly, as Asian health officials in Japan, Korea, Singapore, Hong Kong and China have recently begun banning these illegal ingredients, manufacturers continue to find ways to get their products on the market. According to health officials, manufacturers are still lacing diet pills with illegal ingredients and when one is banned they simply make the same product and market it under a different name and often with a different appearance.

The United States is encountering the same problems. Although the FDA has repeatedly reported drug warnings and deadly side effects to the public, consumers are ignoring health risks and continuing to purchase these diet pills in stores and over the internet. Some of the common side effects include increase in blood pressure, rapid or irregular heart rate, constipation, dry mouth and in some cases anxiety and an inability to sleep. They have also been known to increase the risks of heart attacks, cause severe liver damage and strokes. A list of the most popular Asian Diet pills that have appeared on the FDA warning list include: Zhen de Shou, Imelda Perfect Slim,2 Day Diet, Japan Lingzhi 24 Hour Diet, 3 Day Diet, Herbal Slim, Miaozi Slim, GMP, Superslim, Fruta Planta, Slim Express 360, Slimtech, Somotrin, Triple Slim along with dozens of others. They are all known to have been laced with dangerous levels of sibutramine and N-nitroso fenfluramine and have contributed to a number of deaths internationally and in the US.

With nearly 350 million people being affected by diabetes, scientists are busy trying to find alternative treatments and medications to replace older diabetes medications to keep up with the rising number of people being diagnosed. One medication that was developed and approved by the European Medicines Agency (EMA) in 2009, and later approved by the United States Food and Drug Administration (USFDA) in 2010, has recently been put under the spotlight for its cancer concerns. The drug Liraglutide, marketed under the name Victoza, has been launched in several countries including the US, UK, India, Japan, Germany, Denmark, Ireland, Sweden, Japan, Canada and several others and fills nearly 150,000 prescriptions each month. It was developed by a company by the name of Novo Nordisk to treat individuals with type 2 diabetes.

The drug is injected and reportedly works by mimicking hormones GLP-1, which is responsible for initiating the production of insulin when blood sugars increase to dangerous levels.  It has been proven to stimulate insulin release when blood glucose levels are heightened, lower triglycerides, decrease appetite, maintain body weight, and regenerate beta cells. Some of the mild side effects of Victoza include headache, nausea, vomiting, upset stomach, and cold symptoms. Some of the more serious side effects include swelling or a lump in the throat, shortness of breath, irregular heartbeat, pancreatitis, and signs of infection. It is recommended that people experiencing any of the serious side effects seek emergency medical attention.

After a panel review conducted by the FDA found a significant amount of laboratory cases involving mice and rats showing an increase in malignant or cancerous cells, consumer advocacy groups have taken action to have Victoza removed from the market. Novo Nordisk did not deny the fact that the laboratory experiments were yielding such results, but did state that it is unclear as to whether or not the results were consistent with human subjects. Consumer groups are stating that Victoza places people at risk for thyroid cancer, kidney failure and that there have been thousands of reported cases of pancreatitis. It is believed that Victoza blocks the passage of digestive enzymes by overproducing pancreatic duct cells which causes the pancreas to become inflamed and can become fatal if left untreated. It also puts people at severe risk for pancreatic cancer.

There hasn’t been any scientific proof that over time Victoza does cause cancer, but then again Victoza has only been on the market for three years so there is little data available for long term consequences of this drug. If you are currently taking Victoza, or plan on taking it, please offer your feedback.

The United States Food and Drug Administration has recently approved a new prescription diet drug called Qsymia. Qsymia contains a combination of phentermine (appetite suppressant) and topiramate (anticonvulsant) and is being used to treat obesity and related circumstances such as high blood pressure, sleep apnea, cholesterol and type 2 diabetes. It was developed in California and approved by the FDA by July of 2012. Due to the fact that this drug has just been approved there are few long term studies, but the recent studies that were conducted showed that in just over a year’s time participants lost an average of 37 lbs. There were 4,430 participants in the study and each had a body mass index (BMI) of 27 or greater. They were prescribed Qsymia in three different dosages, 15mg, 7.5mg and a low strength dose of 3.75mg. People who participated in the study also maintained a daily exercise routine and monitored their diets.

With any drug there were side effects experienced. Some of the most common included dry mouth and constipation. Some participants also experienced a tingling sensation in their finger and/or toes. Although none of the participants experienced any severe side effects, the FDA Advisory Committee generated a list of serious side effects to be considered before taking the drug. Some of these side effects include:

• Birth defects such as cleft palate or cleft lip
• Increased heart rate
• paraesthesia
• Suicidal thoughts
• Decrease in vision
• Unusual changes in mood
• Metabolic acidosis
• Osteoporosis
• Loss of appetite
• Hypoglycemia
• Seizures

Some of the participants commented that they enjoyed taking Qsymia and that the drug suppressed their appetite. They also reported that they lost an average of 4lbs per month. Women who were taking Qsymia were encouraged to use a form of birth control to ensure they do not become pregnant due to the fact that an estimated 5 out of every 1000 pregnancies would result in their baby having a birth defect. Before the new diet pill is administered, patients of child bearing age will have to take a pregnancy test to ensure they are not pregnant, and it is recommended that they take a pregnancy test monthly when they are using qsymia. It was reported that 34 women did become pregnant during the study and none of them suffered a defect.

Makers of Qsymia, Vivus, have decided that the drug will not be available from doctors’ offices, but only by mail directly from the company. They fear that the drug can be misused and cause severe or fatal consequences.